Our previous study found that FN secreted by CAFs activates PI3K/AKT signaling pathway through β1 integrin on the surface of tumor cells, inducing EMT of breast cancer cells and contributing to endocrine therapy resistance (48). This evidence concerns the gene AKT1 and breast cancer.